Tel Aviv - Delayed Quote ILA
BioLineRx Ltd. (BLRX.TA)
1.7000
0.0000
(0.00%)
At close: 11:29:25 AM GMT+3
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA | Chief Executive Officer | 499k | -- | 1960 |
| Ms. Mali Zeevi CPA, CPA | Chief Financial Officer | 325k | -- | 1976 |
| Dr. Ella Sorani Ph.D. | Chief Development Officer | 295k | -- | 1968 |
| Mr. John Lacey | Head of Corporate Communications & Investor Relations | -- | -- | -- |
| Mr. Raziel Fried | Treasurer & Budgetary Control Director | -- | -- | -- |
BioLineRx Ltd.
Modi’in Technology Park
2 HaMa’ayan Street
Hevel Modi'in, 7177871
Israel
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 28
Description
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Corporate Governance
BioLineRx Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 31, 2025 at 11:00 AM UTC
BioLineRx Ltd. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
LCTX.TA Lineage Cell Therapeutics, Inc.
158.60
+5.66%
ENLV.TA Enlivex Therapeutics Ltd.
330.60
-0.57%
CMMB Chemomab Therapeutics Ltd.
1.2300
+5.13%
OKUR OnKure Therapeutics, Inc.
2.6700
+2.69%
PPBT Purple Biotech Ltd
2.7750
-1.25%
DRTS Alpha Tau Medical Ltd.
2.6900
+3.07%
MDWD MediWound Ltd.
18.26
+1.73%
PLUR Pluri Inc.
5.85
+21.87%
LSTA Lisata Therapeutics, Inc.
2.3200
-0.85%
ORMP Oramed Pharmaceuticals Inc.
2.2900
0.00%